TD Cowen analyst Gary Taylor downgraded Oak Street Health (OSH) to Market Perform from Outperform with a price target of $39, up from $34. CVS Health’s (CVS) definitive agreement to acquire the company for $39 per share in an all-cash transaction is pending.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OSH:
- Oak Street Health reports FY22 revenue $2.16B, consensus $2.15B
- Oak Street Health downgraded to Neutral from Overweight at JPMorgan
- Oak Street Health downgraded to Market Perform from Outperform at Bernstein
- Oak Street Health downgraded to Market Perform from Outperform at Raymond James
- CVS Health price target raised to $143 from $130 at Jefferies